CAR T-cell therapy is revolutionizing cancer treatment by harnessing the power of the immune system. By reprogramming patients’ own T-cells to attack cancer, it’s achieving unprecedented success rates in once untreatable cancers.
Researchers at the University of Michigan have expanded the use of a gene sequencing method called ribosome profiling to understand protein production in cells. This method, also known as Ribo-seq, has the potential to advance cancer research by identifying new targets for immunotherapy and other treatment approaches. Ribo-seq works by taking a high-resolution snapshot of […]
The virus-like structure of a brain protein may explain cancer-induced memory loss. In some cancer patients, the immune system reacts to tumors by producing antibodies against a protein called Arc. This protein plays a crucial role in memory formation. The antibodies generated resemble a virus and can cross the blood-brain barrier, impacting Arc’s function in […]
A recent study presented at the 2023 ASCO Annual Meeting called DIPLOMA found that minimally invasive distal pancreatectomy (MIDP) is a safe and effective alternative to traditional open surgery for early-stage pancreatic cancer. In a trial with 258 patients, MIDP had similar outcomes to open surgery in terms of tumor removal, lymph node yield, and […]
